StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
001328.SZ$31.52+1.81%
Fair $31.52+0.0%

001328.SZ

Dencare (Chongqing) Oral Care Co., Ltd.

Consumer Defensive / Household & Personal ProductsShenzhen

$31.52

+0.56 (+1.81%)

Fairly Valued+0.0%Fair Value $31.52Fund rank 31/100 · Data gapFallback financials|
SA 34/D
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $134.3M · quality 56.7/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 68/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

34/100

D

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 001328.SZLocal privado en este navegador · Dencare (Chongqing) Oral Care Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$5.4B

P/E

28.7x

↑

EV/EBITDA

22.3x

↑

ROE

12.0%

↑

Gross Margin

52.2%

↑

Debt/Equity

N/A

•
52-Week Range$32
$29$59

TradingView lightweight chart

001328.SZ price, volumen y niveles de valoración

Último $31.52Periodo -44.4%
Fair value: $31.52

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+9.3%

FCF CAGR

+80.8%

FCF margin

9.6%

FCF / Net income

0.91x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.72B · net income $181.1M · FCF $165.5M

2022-FY → 2025-FY

Gross margin

52.2%+11.7% pts

Operating margin

10.5%+0.1% pts

Net margin

10.6%+0.3% pts

FCF margin

9.6%+7.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.72B$1.72B$1.56B$1.38B$1.31B
Net Income$181.1M$181.1M$161.2M$141.3M$134.6M
EBITDA$231.1M$231.1M$209.1M$174.8M$157.9M
EPS1.051.050.940.881.04
Gross Margin52.2%52.2%49.4%44.1%40.5%
Operating Margin10.5%10.5%10.2%8.8%10.4%
Net Margin10.6%10.6%10.3%10.3%10.2%
Balance Sheet
Current Ratio3.483.48———
Cash Flow
Free Cash Flow$165.5M$165.5M$134.3M$106.7M$28.0M
Returns
ROE12.0%12.0%11.1%10.1%24.8%
Valuation
P/E28.6528.6537.1631.06—
EV/EBITDA22.2922.2926.2322.06—
P/B3.613.614.123.12—
Growth & Yield
Revenue Growth10.0%10.0%13.4%4.8%—
EPS Growth11.7%11.7%6.8%-15.4%—
Dividend Yield2.7%2.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

38.6%

muy exigente

EPS terminal req.

$2.80

Spread vs growth

-26.9%

5Y implied EPS CAGR

26.4%

muy exigente

EPS terminal req.

$3.38

Spread vs growth

-14.7%

10Y implied EPS CAGR

17.9%

exigente

EPS terminal req.

$5.45

Spread vs growth

-6.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -40.6%

Total return

-40.6%

Start / end P/E

59.1x → 30.0x

EPS bridge

0.94 → 1.05

Residual

-5.8%

EPS growth+11.7%
Multiple rerating-49.2%
Dividend+2.7%
Residual / FX / buybacks / cross-term-5.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.